|
|
|
| home > white papers > Changing Structural Landscape for Comparator Drug Supply - ADAllen Pharma |
|
|
 WHITE PAPERS |
|
ADAllen Pharma
|
|
Changing Structural Landscape for Comparator Drug Supply
|
|
TransCelerate BioPharma is focused on advancing innovation in R&D,
identifying and solving common R&D challenges and further improving
patient safety, with the goal of delivering more high quality medicines
to patients. In 2013, they announced its Clinical Trial Comparator
Network initiative to show a mutual commitment to offer secure and rapid
supply of comparator drug products. The aim of this article is to
unpack the section on 'Comparator Drugs' and analyse the rationale for
attempting to achieve their objectives.
|
|
|
|
|
|
|
 |
News and Press Releases |
 |
Zenith Technologies win Cork Company of the Year
We’re very proud to announce that last Friday we won the Cork Company of the Year Award in the corporate category.
More info >> |
|
 |
White Papers |
 |
|
7 Common Myths about QP Training Debunked: A Guide for Senior Managers
RSSL
The role of the Qualified Person (QP) in the pharmaceutical industry is mandated by law (Directive 2001/83/EC, Directive 2001/20/EC, UK SI 2012/1916, UK SI 2004/103). Every holder of a relevant Manufacturers Authorisation (human and veterinary) must have at least one QP; without one, no batch of medicinal product can be certified for release for sale.
More info >> |
|
 |
Industry Events |
 |
PDA Europe Annual Meeting 2019
24 June 2019, Hilton Amsterdam
Featuring updates from international regulatory agencies as well as industry, this promises to become another highlight in the 2019 event calendar and is a meeting not to be missed!
More info >> |
|
|
|
